KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Net Income (2018 - 2025)

Historic Net Income for Twist Bioscience (TWST) over the last 8 years, with Q4 2025 value amounting to -$30.6 million.

  • Twist Bioscience's Net Income rose 330.09% to -$30.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$76.6 million, marking a year-over-year increase of 6116.66%. This contributed to the annual value of -$77.7 million for FY2025, which is 6279.57% up from last year.
  • As of Q4 2025, Twist Bioscience's Net Income stood at -$30.6 million, which was up 330.09% from -$27.1 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Net Income ranged from a high of $20.4 million in Q2 2025 and a low of -$85.6 million during Q2 2024
  • Its 5-year average for Net Income is -$42.9 million, with a median of -$42.4 million in 2022.
  • In the last 5 years, Twist Bioscience's Net Income plummeted by 6946.91% in 2021 and then skyrocketed by 12381.51% in 2025.
  • Twist Bioscience's Net Income (Quarter) stood at -$45.6 million in 2021, then rose by 8.21% to -$41.8 million in 2022, then fell by 2.83% to -$43.0 million in 2023, then rose by 26.53% to -$31.6 million in 2024, then grew by 3.3% to -$30.6 million in 2025.
  • Its Net Income stands at -$30.6 million for Q4 2025, versus -$27.1 million for Q3 2025 and $20.4 million for Q2 2025.